What is Abbott's market cap?

Abbott (ABT) has a market capitalization of $166.94B and trades on NYSE.

What is Abbott's revenue and profitability?

Abbott generated $45.1B in trailing twelve-month revenue with net income of $6.3B, representing a net margin of 13.9%. Gross margin stands at 56.3%, with free cash flow of $7.4B. These figures are based on the Q1 2026 filing.

Who are Abbott's competitors?

Abbott's key competitors include Medtronic, Johnson & Johnson, Dexcom, and others. These companies compete in similar markets and product categories.

Who does Abbott partner with?

Abbott's notable partners include Exact Sciences Corporation.

Where is Abbott headquartered?

Abbott is headquartered in United States of America and employs approximately 114,000 people. It has been publicly traded since 1949.

Abbott

ABT

Abbott Laboratories is a global healthcare leader that discovers, develops, manufactures, and sells a diversified portfolio of healthcare products.

Market cap

$166.94B-28.6%

Revenue$45.1B+6.6%

Net income$6.3B-53.5%

Free cash flow$7.4B+10.8%

EPS (diluted)$3.58-53.5%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

April 16, 2026

Revenue$11.2BBeat by $164.4M EPS$1.15Beat by $0.01

Read the full report

Next report

Jul 16, 2026 (In 1 week)

Revenue estimate$12.5B

EPS estimate$1.28

Financials

Q1 2026

Income statement

See full

Revenue$11.2B+7.8%

Gross profit$6.3B+6.5%

Operating income$1.3B-20.6%

Net income$1.1B-18.7%

EPS (diluted)$0.61-19.7%

Balance sheet

See full

Cash & equivalents$6.8B+4.1%

Total debt$34.0B+157%

Total equity$52.1B+6.7%

Total assets$110.43B+35.6%

Cash flow

See full

Operating cash flow$1.3B-7.2%

CapEx$399.0M-17.6%

Free cash flow$916.0M-1.8%

Valuation & ratios

Valuation

See full

Market cap$166.94B-28.6%

Enterprise value$194.18B-19.0%

P/E26.6×+9.9×

P/S3.7×-1.7×

Profitability

See full

Gross margin56.3%+0.4pp

Operating margin17.1%+0.2pp

Net margin13.9%-18.0pp

FCF margin16.3%+0.6pp

Returns & leverage

See full

Return on equity12.4%-18.4pp

Debt / equity0.7×+0.4×

Current ratio1.4×-0.4×

Segments

By segment

See full

Medical Devices$5.5B+13.2%

Diagnostic Products$2.2B+6.1%

Nutritional Products$2.0B-6.0%

Established Pharmaceuticals$1.4B+13.2%

Competitors

By market cap

Johnson & Johnson$643.30B+71.9%

Abbott$166.94B-28.5%

Medtronic$107.31B-5.1%

Boston Scientific$67.3B-56.1%

DexCom$28.4B-13.4%

Merit Medical Systems$4.3B-22.1%

Mannkind$1.3B+18.5%

Opko Health$1.1B+5.9%

By revenue growth

Mannkind+21.2%

Boston Scientific+17.4%

DexCom+16.2%

Merit Medical Systems+11.1%

Medtronic+8.4%

Johnson & Johnson+7.9%

Abbott+6.6%

Opko Health-15.7%

By net margin

Johnson & Johnson21.83%-2.6pp

DexCom19.31%+6.4pp

Boston Scientific17.26%+5.7pp

Abbott13.91%-18.0pp

Medtronic13.2%-0.7pp

Mannkind9.32%-7.8pp

Merit Medical Systems9.03%+0.2pp

Opko Health-36.64%-31.0pp

Profile

Abbott Laboratories is a global healthcare leader that discovers, develops, manufactures, and sells a diversified portfolio of healthcare products. The company operates across the entire care continuum, providing branded generic pharmaceuticals, diagnostic systems, nutritional products, and advanced medical devices. Its core value proposition focuses on improving health outcomes through technological innovation and a broad presence in both developed and emerging markets.

Competitive position

Abbott is a diversified healthcare leader with dominant positions in continuous glucose monitoring and pediatric nutrition, competing through high-tech innovation and brand equity.

GeographiesGlobal, United States, Emerging Markets

Customer segmentsHealthcare Providers, Government Agencies, Retail Consumers, Laboratories

Business modelManufacturing, B2B Distribution, Direct-to-Consumer, Licensing

SuppliersRaw material suppliers, Specialized component manufacturers, Biopharmaceutical R&D partners, Third-party logistics providers

CustomersHospitals and health systems, Retail pharmacies and grocery chains, Government health departments, Individual patients and consumers

CountryUnited States of America

Listed1949

Employees114.0K

CEORobert Ford

SectorHealthcare

IndustryMedical - Devices

Websiteabbottinvestor.com

FilingsSEC EDGAR

Ask your AI about Abbott.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Abbott's market cap?: Abbott (ABT) has a market capitalization of $166.94B and trades on NYSE.
What is Abbott's revenue and profitability?: Abbott generated $45.1B in trailing twelve-month revenue with net income of $6.3B, representing a net margin of 13.9%. Gross margin stands at 56.3%, with free cash flow of $7.4B. These figures are based on the Q1 2026 filing.
Who are Abbott's competitors?: Abbott's key competitors include Medtronic, Johnson & Johnson, Dexcom, and others. These companies compete in similar markets and product categories.
Who does Abbott partner with?: Abbott's notable partners include Exact Sciences Corporation.
Where is Abbott headquartered?: Abbott is headquartered in United States of America and employs approximately 114,000 people. It has been publicly traded since 1949.